Literature DB >> 16846600

Conditional gene modification in mouse liver using hydrodynamic delivery of plasmid DNA encoding Cre recombinase.

Huan Zhang Zhu1, Wei Wang, Deng Min Feng, Yin Sai, Jing Lun Xue.   

Abstract

The success of Cre-mediated conditional gene targeting in liver of mice has until now depended on the generation of Cre recombinase transgenic mice or on viral-mediated transduction. Here, we sought to establish the feasibility of using hydrodynamic gene delivery of Cre recombinase into liver, using a ROSA26 EGFP mouse. The expression of EGFP and beta-galactosidase was exclusively detected in the liver of mice treated with hydrodynamic gene delivery of Cre recombinase, as assessed with fluorescence microscopy and X-Gal staining, respectively; Southern blotting also showed that Cre mediated recombination occurred specifically in the liver and not in other organs. The Cre mediated recombination reached about 61% of hepatocytes of mouse after repeated injection, as analyzed by flow cytometry. These results demonstrate that Cre recombinase can be transferred to the liver of mice through a simple hydrodynamic gene-delivery approach and can mediate efficient recombination in hepatocytes. Thus, hydrodynamic gene delivery of the Cre recombinase provides a valuable approach for Cre-loxP-mediated conditional gene modification in the liver of mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16846600     DOI: 10.1016/j.febslet.2006.06.094

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Nuclear double-fluorescent reporter for in vivo and ex vivo analyses of biological transitions in mouse nuclei.

Authors:  Justin R Prigge; James A Wiley; Emily A Talago; Elise M Young; Laura L Johns; Jean A Kundert; Katherine M Sonsteng; William P Halford; Mario R Capecchi; Edward E Schmidt
Journal:  Mamm Genome       Date:  2013-09-11       Impact factor: 2.957

2.  Hematopoietic MyD88 and IL-18 are essential for IFN-γ-dependent restriction of type A Francisella tularensis infection.

Authors:  Jerod A Skyberg; Carolyn A Lacey
Journal:  J Leukoc Biol       Date:  2017-09-26       Impact factor: 4.962

3.  In vivo inhibition of focal adhesion kinase causes insulin resistance.

Authors:  Bharti Bisht; K Srinivasan; Chinmoy S Dey
Journal:  J Physiol       Date:  2008-06-26       Impact factor: 5.182

4.  Optimized adeno-associated virus 8 produces hepatocyte-specific Cre-mediated recombination without toxicity or affecting liver regeneration.

Authors:  Karen J Ho; Caroline E Bass; Alexander H K Kroemer; Chunyan Ma; Ernest Terwilliger; Seth J Karp
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-06-05       Impact factor: 4.052

5.  Intracellular interleukin-32γ mediates antiviral activity of cytokines against hepatitis B virus.

Authors:  Doo Hyun Kim; Eun-Sook Park; Ah Ram Lee; Soree Park; Yong Kwang Park; Sung Hyun Ahn; Hong Seok Kang; Ju Hee Won; Yea Na Ha; ByeongJune Jae; Dong-Sik Kim; Woo-Chang Chung; Moon Jung Song; Kee-Hwan Kim; Seung Hwa Park; Soo-Hyun Kim; Kyun-Hwan Kim
Journal:  Nat Commun       Date:  2018-08-16       Impact factor: 14.919

6.  A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genome.

Authors:  Robert L Kruse; Mercedes Barzi; Xavier Legras; Francis P Pankowicz; Nika Furey; Lan Liao; Janming Xu; Beatrice Bissig-Choisat; Betty L Slagle; Karl-Dimiter Bissig
Journal:  JHEP Rep       Date:  2021-02-06

7.  Hydrodynamic delivery of Cre protein to lineage-mark or time-stamp mouse hepatocytes in situ.

Authors:  Katherine M Sonsteng; Justin R Prigge; Emily A Talago; Ronald K June; Edward E Schmidt
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

8.  Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet Formation.

Authors:  Sonja M Kessler; Stephan Laggai; Elien Van Wonterg; Katja Gemperlein; Rolf Müller; Johannes Haybaeck; Roosmarijn E Vandenbroucke; Manfred Ogris; Claude Libert; Alexandra K Kiemer
Journal:  Front Physiol       Date:  2016-04-25       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.